BIOLOGIC/DISEASE-MODIFYING ANTIRHEUMATIC DRUG (DMARD)
Orencia is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat active psoriatic arthritis in adults. Orencia may be referred to by its drug name, abatacept.
Orencia is an immunomodulator, a drug that modulates the immune system. It is also considered a biologic. It is a fusion protein created by genetic engineering. Orencia is believed to work by modifying the immune system. Specifically, Orencia binds to antigen-presenting cells and prevents them from signaling T cells to attack the connective tissues.
How do I take it?
Orencia is administered as a subcutaneous injection once a week or intravenous infusion once every four weeks.
Orencia is available as a single-use, prefilled syringe or auto-injector for subcutaneous injection.
The FDA-approved label for Orencia lists common side effects including headache, upper respiratory tract infections, nausea, and cold or flu symptoms.
Rare but serious side effects listed for Orencia can include hypersensitivity reactions and increased risk for infections, including severe infections.
For more details about this treatment, visit:
Orencia — Bristol Myers Squibb